TGFB1 and neoplasm: Regulatory T-cells thrive in the cancerous microenvironment, producing excess TGFβ1, preventing the proliferation of other immune cells reducing immune responses to tumors, as well as enhancing tumor cell proliferation (Franco et al., 2016).